As of May 25
| +0.06 / +1.24%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +124.49% increase from the last price of 4.90.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.